Jul 2026
Clinical and molecular prognostic factors in newly diagnosed pediatric T-cell lymphoblastic lymphoma: a prospective, multicenter, single-arm phase 2 clinical trial
Adjusting the risk stratification based on treatment response significantly improved the overall prognosis of T-LBL, and molecular genetic risk factors might contribute to further risk stratification and provide potential therapeutic targets.
Xia Guo, Chao-Ban Wang, Yue-Jia Tang et al.
· World Journal of Pediatrics · 0 citations